Boxer Capital, LLC
CIK 1465837 · last filed 2023-10-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MRTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 300
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNGX | 13,937,092 | $23.89 | $332.96M | -$11.20M | 1 | 2023-10-11 | |
| RAIN | Director | 1,152,212 | $0.60 | $694.4K | $54.57M | 2 | 2023-05-24 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Director | 4,207,086 | $1.12 | $4.71M | $133.68M | 8 | 2021-11-24 |
| PMVP | 982,708 | $1.31 | $1.29M | $85.50M | 1 | 2020-09-29 | |
| iTeos Therapeutics, Inc. (ITOS) Delisted | 10%+ Owner | 2,943,568 | $10.15 | $29.88M | $108.30M | 1 | 2020-07-29 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 1,765,560 | $58.70 | $103.64M | -$122.81M | 8 | 2020-01-14 |
| SLDB | 10%+ Owner | 231,551 | $6.19 | $1.43M | -$4.45M | 1 | 2019-03-28 |
| Pernix Sleep, Inc. (SOMX) Delisted | 109,561 | — | — | -$5.40M | 2 | 2009-08-28 |
Recent Filings · Page 3 of 3
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-26 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +80,472 | $1.18M | EDGAR |
| 2017-12-08 | Odonate Therapeutics, Inc. (ODT) Delisted | Buy (P) | +1,249,998 | $30.00M | EDGAR |
| 2017-10-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Exer (X) | +535,932 | $4.21M | EDGAR |
| 2016-03-17 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −474,158 | $0 | EDGAR |
| 2016-01-15 | Mirati Therapeutics, Inc. (MRTX) Delisted | Other (J) | −791,139 | $0 | EDGAR |
| 2009-08-28 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −285,000 | -$752.4K | EDGAR |
| 2009-07-29 | Pernix Sleep, Inc. (SOMX) Delisted | Sell (S) | −1,500,000 | -$4.65M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.